Emulate, Inc.’s Post

Come visit us at BioTechX in Basel next week to discuss all topics around AI in Drug Discovery and Development and Clinical Trial Analytics Services. We look forward to meeting colleagues from across the industry. My colleague Greg Lever will also be presenting a great talk "Guiding Assets from Discovery through Development" (which is sitting under in the AI in Drug Development and Discovery track), on: ~ Demonstrating how Large Language Models enable you to scan the emerging scientific landscape and explore new targets, new markets, new indications, identify obstacles and assess development timelines ~ Exploring AI/ML approaches that can be used to identify new targets for assets, identify associations between targets and indications, and repurpose existing drugs for new indications ~ Describing downstream applications of AI/ML to improve patient identification and recruitment, including within underrepresented populations Join us at #biotechxEU — booth 702. https://bit.ly/480H6QG #pharmaceutical #ai #drugdiscovery #development #BiotexhxEU

The multi-billion-dollar BioPharma industry is undergoing more change than ever before. The impending presidential election, ever escalating innovations in tech and AI, new drug legislation, and inflation all have an impact and it’s extremely challenging to predict the net effect.        In our latest industry insight report, we investigate broader industry trends and also delve into talent insights for Massachusetts; the state that continues to be a beacon of innovation and growth. 👀 Sneak preview: from our research, Rapport Therapeutics, Ardelyx, Inc., Flagship Pioneering and Sumitomo Pharma America, Inc. were the fastest growing companies in their size bracket.  Read the full report to find out who else featured, link in the comments ⬇

🔬 Zealand Pharma : Harnessing the Power of Peptides 🧬 From Denmark's vibrant biotech landscape, Zealand Pharma emerges, redefining medical possibilities with peptide-based innovations. 🩺 Comprehensive therapeutic pipeline. 🧪 Tailored drug designs for precise solutions. 🤝 Global collaborations for faster breakthroughs. #PharmaInnovation #PeptideMedicine #DenmarkInnovation #HealthTech #NordicTech 💊 Link in the comments!

The BioCentury-BayHelix East-West Biopharma Summit kicks off on Monday! We invite you to join us next week as we network, discuss global development strategies, and explore innovative solutions to sustain advancements in the biopharma industry. You won't want to miss: ➤ All-Star Line-Up of 60+ Speakers, including Christopher Viehbacher of Biogen, Christiana Bardon M.D. of MPM BioImpact, Robert Plenge of Bristol Myers Squibb, and many more. ➤ Strategic Sessions: Our carefully curated panels and sessions will provide valuable and actionable takeaways on cutting-edge subjects. ➤ 50+ Presenting Companies: Discover the latest advancements, products, and technologies from the Presenting Companies Class of 2023, including Alloy Therapeutics, Inc., Candel Therapeutics, Inceptor Bio, Jacobio Pharma, Prokarium, TandemAI,  and more. ➤ 1:1 C-Level Meetings: Meet your next partner or investor during our four days of strategic partnering meetings. ➤ McKinsey & Company Conference Report: Insights Partner McKinsey & Company returns to the Summit to unveil its conference report on the impact of AI on global biotechs. Hear more from McKinsey at the opening keynote address and the CEO and investor roundtable. To view the schedule and learn more about who you will meet at the Summit, please download the conference brochure: https://ow.ly/SNWP50PR9kz Register now - in-person and digital passes available: https://ow.ly/Jspf50PR9kA #biotech #biopharma #pharma #AI #dealmaking #VC #investors #biocenturyeastwest

Explore our upcoming events and kickstart 2024 with cutting-edge insights! 🌟 From pharma innovations to immuno-oncology advancements, here's what's on the horizon: [Full event calendar in comments 📆] Let's connect, collaborate, and innovate together! 💡 #EventCalendar #PharmaTecSeries23 #OmicsSeries23 #CellSeries23 #BiologicsSeries23 #BiomarkersSeries23 #ImmunoSeries23 #DiscoverySeries23 #FormulationSeries23

On 8th November, Nicole Kar, Global Head of our Antitrust and Foreign Investment Group, will be speaking on the panel at the FT’s Global Pharma and Biotech Summit, where she will be discussing how regulators are viewing biotech and pharma consolidation. Click the link to find out more! #FTPharma

On 8th November, Nicole Kar, Global Head of our Antitrust and Foreign Investment Group, will be speaking on the panel at the FT’s Global Pharma and Biotech Summit, where she will be discussing how regulators are viewing biotech and pharma consolidation. Click the link to find out more! #FTPharma

🚀 We are thrilled to announce that ArgusEye has been awarded the prestigious Bio-X Accelerate grant! 🎉 This significant support will propel our innovation to new heights. With the added resources: * We will accelerate the development of an in-line probe for the upstream process of biologics. * Our advancements will include sensor chips designed for continuous measurements throughout the entire bioprocess cycle. * This addition to our product portfolio will significantly enhance ArgusEye's offering, enabling comprehensive in-line data coverage across the entire bioprocess chain. This acceleration aligns perfectly with our mission: transforming bioprocessing through real-time data. With this injection of resources, we are one step closer to revolutionizing how bioprocessing is done, ensuring more efficient and effective outcomes in the industry.   We thank STUNS Life science for selecting us and extend our heartfelt congratulations to our fellow winners: Strike Pharma AB, Rarity Bioscience , Readily Diagnostics, and Phenaros Pharmaceuticals.    The goals of the Bio-X Accelerate program are to fast-track innovation in the health and life science industries, and we are honored to be part of this transformative initiative. The kick-off is set for this autumn, and you can join us during the pitch event here: https://lnkd.in/diurc_gd   #Innovation #Bioprocessing #RealTimeData #BioXAccelerate #Healthcare #LifeSciences #ArgusEye

Thanks for sharing Ravikumar Ummadisingu, the article gives a super summary of our Gerresheimer’s high value portfolio!

𝗨𝗽𝗰𝗼𝗺𝗶𝗻𝗴 𝘄𝗲𝗯𝗶𝗻𝗮𝗿: Get to know how to make a process for the development and manufacture of Biological Drugs more efficient, cost-effective and user-friendly. We developed a series of innovative tools in the iConsensus project that we love to share! During our online event: In conversation with iConsensus, they will share their results and demonstrate how they have addressed key challenges in health research and innovation. 🚨 Online event 📅 10 October 2023 ⌚ 14:00-15:30 CET ➡ Register here: europa.eu/!rdxnjp 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲: Veronique Chotteau, KTH Royal Institute of Technology Marc D. Voss, PhD, MBA, Sanofi Luc Kupers, formerly Sanofi Fabien ABEILLE, Micronit Åsa Emmer, KTH Royal Institute of Technology Aman Russom, KTH Royal Institute of Technology Moderated by IHI's Salome Koussoroplis #BioPharma #BioManufacturing #DrugDevelopment #H2020 #MedTech Vertaling weergeven